Systemic and cardiac susceptibility of immune compromised mice to doxorubicin

Cardio-Oncology
Amanda J Favreau-LessardIlka M Pinz

Abstract

Anthracycline chemotherapy is an effective and widely used treatment for solid tumors and hematological malignancies regardless of its known cardiotoxicity. The mechanisms of the cardiotoxicity are not fully understood and methods to protect the heart during or following anthracycline chemotherapy are currently unclear. In order to examine the efficacy of human cell based therapy in anthracycline-induced injury, we characterized a mouse model using an immune compromised strain of mice capable of accepting human cells. Immune compromised mice (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ) were repeatedly exposed to pharmaceutical grade doxorubicin (0.5 mg/kg - 4 mg/kg). Cardiotoxicity was assessed by echocardiography and μCT imaging of the coronary vascular bed as well as by flow cytometry and by histological assessments of anthracycline-induced cardiac tissue damage. The immune compromised mice were highly susceptible to doxorubicin treatment. Doxorubicin induced both systemic and cardiac toxicities. Gastrointestinal and hepatic injury occurred at 4 mg/kg and 1.5 mg/kg dosing while mice receiving 0.5 mg/kg weekly only displayed hepatic damage. Repeated exposure to 0.5 mg/kg anthracyclines resulted in cardiac toxicity. Flow cytometric analy...Continue Reading

References

May 24, 1996·The Journal of Biological Chemistry·Y J KangP N Epstein
May 23, 2001·Toxicology Letters·S ZhouK B Wallace
May 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Leonard D ShultzRupert Handgretinger
Dec 13, 2005·Biochimica Et Biophysica Acta·Matthew B Wolf, John W Baynes
Jun 25, 2009·Current Medicinal Chemistry·Cristina CarvalhoPaula I Moreira
Sep 16, 2010·Current Hypertension Reports·Carrie Anna Geisberg, Douglas B Sawyer
Mar 3, 2011·Nature Reviews. Clinical Oncology·Laurence ZitvogelGuido Kroemer
Oct 30, 2012·Nature Medicine·Sui ZhangEdward T H Yeh
Jul 30, 2015·Upsala Journal of Medical Sciences·Lena Claesson-Welsh
Apr 2, 2016·Physiological Reports·M A Hassan TalukderIlka M Pinz
Jul 3, 2016·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Shirley M BluethmannJulia H Rowland
Nov 2, 2016·Proceedings of the National Academy of Sciences of the United States of America·Markus RäsänenKari Alitalo
Jan 2, 2018·Journal of Molecular and Cellular Cardiology·Sergey RyzhovDouglas B Sawyer
Dec 6, 2018·Toxicology and Applied Pharmacology·Varsha G DesaiJames C Fuscoe
Jan 29, 2019·Frontiers in Cardiovascular Medicine·Icia Santos-ZasHafid Ait-Oufella

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
flow cytometry
biopsies
coronary artery bypass

Software Mentioned

VisualSonics Systems
Scanco
GraphPad
Prism

Related Concepts

Related Feeds

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

The New England Journal of Medicine
J M Carter, P S Bergin
Cancer Treatment Reviews
D V UnverferthS P Balcerzak
Progress in Cardiovascular Nursing
K L GradyC G Varricchio
The New England Journal of Medicine
Emil R HayekEsther Rehmus
Nederlands tijdschrift voor geneeskunde
J W PilonJ A Taminiau
© 2021 Meta ULC. All rights reserved